Infectious Disease & Vaccines
| 3 min read
Before its COVID-19 era hype, ivermectin was already a wonder drug for parasitic infections. Its renewed interest underscores the need for effective COVID-19 treatments and communication on proper research study design and analysis.
Available on Demand
LIVE November 29th, 2021 at 11:00 AM ET
Investigating the pathophysiology and spread of human viruses
Investigating the pathophysiology and spread of human viruses
| 3 min read
Increasing cAMP production blocks tuberculosis’ cholesterol metabolism, impairing its pathogenesis in mice.
| 5 min read
Cardiologist Sheba Meymandi hopes to prevent the deadly cardiac effects of Chagas disease with increased screening and knowledge of the disease.
| 8 min read
Scientists continue to ring alarm bells about the risks associated with the continued misuse of antimicrobials and advocate for innovative treatments, improved surveillance, and greater public health education.
| 3 min read
A new delivery system initially developed to treat asthma sends corticosteroids deep into the lungs where COVID-19 infects cells, potentially slowing viral replication.
Available on Demand
LIVE October 26th, 2021 at 11:00 AM ET
Experts will discuss recent advances in screening strategies to more efficiently identify therapeutic candidates for infectious diseases such as schistosomiasis and COVID-19.
Experts will discuss recent advances in screening strategies to more efficiently identify therapeutic candidates for infectious diseases such as schistosomiasis and COVID-19.
| 4 min read
A GLP-grade non-replicative Leishmania major parasite protects hamsters from lethal leishmaniasis infection, setting the stage for human clinical trials and the first potential vaccine for leishmaniasis.
| 5 min read
Researchers employ CRISPR technology in a variety of creative ways to control the spread of vector-borne illnesses.
| 9 min read
Respiratory viruses are the most common cause of asthma attacks, but COVID-19 does not send asthma patients to the hospital more often than others. Some researchers suspect that having asthma may actually protect patients from severe COVID-19.
| 2 min read
Through research experience, scientists develop a strong sense of resiliency. The COVID-19 pandemic put that resiliency to the test, and now as vaccination rates increase and communities begin to open up, it’s time to take a breath.
| 3 min read
Experiments in ferrets show that a prophylactic spray cuts SARS-CoV-2 replication by more than 90 percent by priming the innate immune system.
